Publications

Relocation of the European Medicines Agency

There are many reasons why Dublin is the ideal location for the European Medicines Agency (EMA). Dublin can provide a sustainable and smooth transition for the EMA, the European regulatory network, its stakeholders and most importantly the people of Europe. Relocation of the European Medicines Agency – Dublin, where the world comes to work www.emadublin.ie

Department of Health Consolidated Salary Scales w.e.f. 1/4/2017 in accordance with FEMPI 2015 and the Public Service Stability Agreements 2013 – 2018, (The Lansdowne Road Agreement)

Department of Health Consolidated Salary Scales w.e.f. 1/4/2017 in accordance with FEMPI 2015 and the Public Service Stability Agreements 2013 – 2018, (The Lansdowne Road Agreement) These scales must be read in conjunction with Department of Health Circular 6/2017.     Pay Scales for health sector employees returning from abroad Appointment to the appropriate point

Tobacco Free Ireland Annual Report 2015

Tobacco Free Ireland, the report of the Tobacco Policy Review Group, was endorsed by Government, and published in October 2013. It builds on existing tobacco control policies and legislation already in place in this country, and sets a target for Ireland to be tobacco free (i.e. with a smoking prevalence rate of less than 5%)

Health Research Board Report – Assisted reproductive technologies: International approaches to public funding mechanisms and criteria. An evidence review

Officials in the Department of Health are currently drafting the General Scheme of legislative provisions for assisted human reproduction (AHR). In the context of drafting this comprehensive piece of legislation, the question of public funding has arisen. In order to assist in determining how public funding for fertility treatment might potentially be provided in Ireland,

Interim Report on National Rare Disease Plan for Ireland 2014-2018

This is a summary/detailed Interim Report on the implementation of the National Rare Disease Plan published in 2014 by the Department. It provides an update on progress with the implementation of each of the 48 recommendations in the National Plan. These recommendations cover a number of areas pertinent to rare diseases including information & research;

Page 1/66